EuBiologics Co., Ltd. (206650.KQ)
KRW 13100.0
(0.08%)
KRW 13100.0
(0.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.69 Billion KRW | 304.3% |
| 2022 | -3.76 Billion KRW | 47.87% |
| 2021 | -7.22 Billion KRW | -21.25% |
| 2020 | -5.96 Billion KRW | -160.78% |
| 2019 | 9.8 Billion KRW | 84.66% |
| 2018 | 5.31 Billion KRW | 208.52% |
| 2017 | -4.89 Billion KRW | 29.2% |
| 2016 | -6.91 Billion KRW | -154.05% |
| 2015 | -2.72 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.37 Billion KRW | -74.9% |
| 2024 Q2 | -1.64 Billion KRW | -169.25% |
| 2023 Q3 | -3.3 Billion KRW | -265.85% |
| 2023 Q2 | 1.99 Billion KRW | 538.7% |
| 2023 FY | 7.69 Billion KRW | 304.3% |
| 2023 Q1 | -454 Million KRW | 85.23% |
| 2023 Q4 | 9.46 Billion KRW | 386.52% |
| 2022 Q1 | -304.22 Million KRW | 87.6% |
| 2022 FY | -3.76 Billion KRW | 47.87% |
| 2022 Q3 | -950.43 Million KRW | -269.68% |
| 2022 Q2 | 560.13 Million KRW | 284.12% |
| 2022 Q4 | -3.07 Billion KRW | -223.44% |
| 2021 Q3 | 1.54 Billion KRW | 162.07% |
| 2021 Q1 | -3.83 Billion KRW | 0.0% |
| 2021 FY | -7.22 Billion KRW | -21.25% |
| 2021 Q2 | -2.48 Billion KRW | 35.28% |
| 2021 Q4 | -2.45 Billion KRW | -259.28% |
| 2020 FY | -5.96 Billion KRW | -160.78% |
| 2019 FY | 9.8 Billion KRW | 84.66% |
| 2018 FY | 5.31 Billion KRW | 208.52% |
| 2017 FY | -4.89 Billion KRW | 29.2% |
| 2016 FY | -6.91 Billion KRW | -154.05% |
| 2015 FY | -2.72 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | -19.54 Billion KRW | 139.397% |
| CMG Pharmaceutical Co., Ltd. | 5.72 Billion KRW | -34.478% |
| Celltrion Pharm, Inc. | 36.07 Billion KRW | 78.656% |
| Huons Global Co., Ltd. | 122.92 Billion KRW | 93.737% |
| DongKook Pharmaceutical Co., Ltd. | 66.87 Billion KRW | 88.487% |
| Enzychem Lifesciences Corporation | -14.35 Billion KRW | 153.629% |
| Humedix Co., Ltd. | 37.31 Billion KRW | 79.365% |
| Boditech Med Inc. | 33.44 Billion KRW | 76.978% |
| FutureChem Co.,Ltd | -8.4 Billion KRW | 191.57% |
| Huons Co., Ltd. | 59.79 Billion KRW | 87.124% |
| BNC Korea Co., Ltd. | 10.81 Billion KRW | 28.835% |
| AptaBio Therapeutics Inc. | -16.37 Billion KRW | 147.022% |